Creating a rare disease strategy would mean that Canada would develop a drug review process that fairly assesses medicines for rare diseases, including critical drugs for cystic fibrosis.
We believe that people with CF and their loved ones have waited long enough for equitable access to medicine. CF is a progressive disease and people with CF do not have time to wait. We need a pan-Canadian rare disease strategy now!
Together, we can make a difference.